© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Fenbufen traces its roots to the golden age of anti-inflammatory drug discovery during the 1970s, a period marked by the medical community’s rush to create effective pain relievers beyond aspirin. Teams of chemists focused on the arylalkanoic acid class, chasing hope for new agents to manage chronic pain and inflammation. Fenbufen emerged amid competition, making its case through consistent results in both laboratory and clinical settings. Over decades, this compound shook off shadows of older drugs’ side effects, slowly winning a dedicated slot on pharmacy shelves across several countries and continents. Medical professionals came to appreciate its performance, despite periodic scrutiny about long-term use. Regulatory hurdles sometimes shifted its market journey, yet patient demand for alternative solutions to rheumatoid arthritis and osteoarthritis helped fuel continued clinical interest and research investment.
The modern market recognizes fenbufen as a trusted non-steroidal anti-inflammatory drug primarily indicated for arthritis, musculoskeletal pain, and acute injuries. Its typical forms include tablets, capsules, and topical preparations. Global trade lists its name among familiar NSAIDs, though regional availability varies due to regulatory attitudes and market forces. The World Health Organization’s lists sometimes mention it, though not with the same prominence as ibuprofen or naproxen. Local producers or generic manufacturers often keep its price accessible, since fenbufen itself, as an established molecule, no longer enjoys brand exclusivity. Its familiarity in hospitals and pharmacies signals ongoing relevance for patients unable to tolerate more aggressive NSAIDs.
Fenbufen appears as a white to off-white crystalline powder—chemists often note its slight bitterness and practically insoluble nature in water, which shapes its formulation challenges. Its melting point lands near 178 to 181 degrees Celsius. The molecule features a biphenyl backbone—a structure often seen in other NSAIDS—which shapes both its biological effects and synthetic modifications. Solubility works better in organic solvents, and this quirk influences its pharmaceutical design, from binders in tablets to the kinds of excipients that play nice during granulation. Chemists pay close attention to such properties when scaling up for industrial manufacturing, keeping impurities low, and optimizing bioavailability.
At the pharmacy level, a typical bottle states fenbufen free acid content per dose—often 200 mg or 400 mg per unit. The label lays out excipients, storage conditions (room temperature, protected from moisture), batch number, and manufacturer’s address, all in line with local pharmacopoeial standards. For clinical use, detail matters—labels must remind both patient and pharmacist of possible interactions (other NSAIDs, blood thinners), and doctors refer to literature summarizing its anti-inflammatory, antipyretic, and analgesic actions. Pharmacists appreciate clear directions for dose adjustments in elderly or renal-impaired patients. The paperwork ensures product traceability and patient safety, a consistent demand under increasing scrutiny from regulators and public watchdogs.
Large-scale production begins with the synthesis of the biphenyl core, often selecting benzoyl chloride and phenylacetic acid derivatives as building blocks. Controlled Friedel-Crafts acylation sets up the right connections on the aromatic rings, followed by a carboxylation to introduce the critical acid group. Purification steps rely on crystallization—a key process that removes colored impurities—and subsequent filtration. Analytical chemists lean on HPLC, NMR, and IR spectroscopy to verify every batch, while QA teams test each lot for potency, uniformity, and absence of residual solvents. Over the years, manufacturing lines have shifted toward greener solvents and catalysts, a move both to protect workers and minimize environmental footprint.
Fenbufen’s structure allows for modest chemical tweaks, though most research sticks close to its parent scaffold. The biphenyl rings tolerate halogenation or minor substitutions, which can alter metabolic fate or side effect risk. Derivatives show activity profiles that spark curiosity but rarely outperform the parent in both safety and effectiveness. Some research groups have tried linking fenbufen motifs to peptide or sugar groups, hoping for selective targeting or better gastrointestinal safety. Patent records show a steady stream of such efforts, signaling ongoing relevance in medicinal chemistry labs worldwide. At the core, the molecule resists profound change—the original design struck a sturdy balance between efficacy and manageable side effects, a testimony to the careful early work by its inventors.
Chemists and clinicians recognize fenbufen under several aliases, reflecting different naming conventions across countries and suppliers: Biphenylacetic acid, Fenbufenum, or simply by branded labels like “Lodine” (noting some brands differ regionally or are now discontinued). Suppliers catalog it under CAS number 36330-85-5. Generics use local names, all backed by the international nonproprietary name. Doctors in clinical practice swap between terms depending on patient location and familiarity, while chemical suppliers mark each drum or bottle with precise chemical identity, sparing no confusion in large-scale operations.
Handling fenbufen in both the lab and production floor means following stringent occupational health rules. Operators use gloves, masks, and precise ventilation—this ensures both personal safety and product purity. Standard operating procedures require regular cleaning, document every step, and monitor for cross-contamination. Risk assessments flag dust generation and waste solvents as priority hazards. For patients, package inserts list possible gastrointestinal, renal, and hypersensitivity reactions. Regulatory authorities demand batch-by-batch testing for stability, shelf-life, and impurity levels. Every shipment, whether across town or oceans, travels with signed analysis certificates, traceability records, and emergency phone numbers.
Doctors gravitate toward fenbufen for cases of rheumatoid arthritis, osteoarthritis, back pain, and post-injury inflammation. Its profile offers relief for those who struggle with classic NSAIDs like ibuprofen because of side effects or weak response. Orthopedic and rheumatology clinics keep it handy for moderate to severe pain, scripting it as a short-course remedy more often than a lifelong daily staple. Veterinary medicine sometimes relies on it, too, since it works in companion animals under tightly controlled dosing regimens. Sports physicians turn to topical gel forms, applying them to sprains and strains, seeking the local benefit without causing systemic burden.
Research on fenbufen has shifted focus over the decades. Early years probed its mechanism, finding it inhibits cyclooxygenase enzymes—classic NSAID action. Later work measured comparative outcomes in head-to-head trials with naproxen, diclofenac, and ibuprofen, searching for any unique angle. Newer studies focus on delivery systems, like sustained-release tablets, nanoparticle suspensions, and dermal patches. Some research teams look at combination products—pairing with proton pump inhibitors to protect the stomach, or in cocktails with antibiotics for complicated infections. Each paper, grant, and patent continuously asks if there is new territory to claim for a molecule that’s spent decades in the public’s service. Big breakthroughs have slowed, yet academic curiosity keeps the torch burning.
Fenbufen’s toxicity profile looks familiar to anyone studying NSAIDs. Researchers observe dose-dependent gastrointestinal ulceration, kidney stress, and liver enzyme elevations in long-term or high-dosage animal studies. Some patient groups, especially the elderly and those with existing organ challenges, show higher rates of side effects. Post-market surveillance, especially after the 1990s, uncovered rare hypersensitivity reactions. Strict warning labels prompt clinicians to monitor for blood in stools, changes in urine, or allergic rash. Regulatory agencies compare fenbufen’s risk side-by-side with similar agents, constantly updating advice to minimize those rare but serious complications. Patient education programs emphasize knowing warning signs, seeking help early, and never exceeding prescribed doses.
Looking ahead, fenbufen plays a quieter role in the pain relief arsenal—overshadowed in some places by newer drugs and reformulations. Still, it delivers value for specific patient needs. Generic access keeps costs low, a crucial point as health systems tighten drug budgets. Research into precision medicine may someday uncover patient subgroups who benefit most from fenbufen, optimizing outcomes and minimizing adverse events. Pharma companies show less appetite for blockbuster innovations here, yet academic researchers and small biotechs still examine delivery tweaks, prodrugs, or combination therapies. As medicine continues the quest for safer, targeted inflammation control, fenbufen stands both as a tried-and-true workhorse and a constant reminder of the value in old molecules.
Most folks deal with aches or pain at some point. For many, reaching for a pain reliever feels as familiar as grabbing a morning coffee. Fenbufen falls into the group called nonsteroidal anti-inflammatory drugs, or NSAIDs for short. It works to ease pain and lower swelling. Doctors have used it to help people get some relief from joint pain, muscle aches, headaches, and the nagging discomfort tied to arthritis.
Living with long-term pain drags a person down, saps energy, and can eat away at mental health. I remember my uncle, a retired carpenter, struggling with arthritis. Stiffness in his hands made small tasks feel big. On days when over-the-counter meds barely helped, prescription NSAIDs like fenbufen brought needed relief. Unlike some painkillers, this drug can help by not just dulling the brain’s signal of pain, but by calming inflammation at its source.
Doctors pay attention to both how well a drug works and its safety. Fenbufen blocks a substance called prostaglandin, which is involved in causing pain and swelling. By doing that, joints move a little easier and people can get back to everyday activities, whether it’s gardening or keeping up with kids. Research has shown that NSAIDs, including fenbufen, can make a real difference in quality of life if pain gets in the way of sleep or work.
Every medicine comes with trade-offs. People often expect more from painkillers than they can safely give. Fenbufen, being part of the NSAID family, brings risks that show up most often in the gut or heart. My old neighbor, after months on NSAIDs, landed in the ER with stomach trouble. Turns out, these drugs can trigger ulcers or bleeding, sometimes with little warning. The longer someone takes these medicines—especially at high doses—the bigger the risk.
For those with a history of heart problems or kidney issues, the risk creeps up even more. Fenbufen may also interact with other medicines that thin the blood or impact blood pressure. Good nurses and pharmacists ask about all the bottles patients have at home, but not everyone speaks up. That makes honest conversations with healthcare pros crucial.
Education goes a long way. If more people understood what to look out for—belly pain, dark stools, shortness of breath—they’d spot problems sooner. Doctors often suggest using the lowest dose for the shortest time. Not every ache needs a strong prescription either. Many find relief by combining milder options, heat, exercise, or physical therapy. Movement, even gentle walks, keeps joints limber and helps curb pain naturally. Community health resources, like workshops on joint care, bring people together and open doors to new coping tools.
Fenbufen isn’t right for everyone, but in the hands of a skilled doctor, it can help folks reclaim comfort in daily routines. Staying mindful of side effects—and always checking in with a healthcare provider—makes the difference between healthy relief and risky shortcuts.
Fenbufen isn’t a household name, but it sits on pharmacy shelves as a medicine for pain and swelling. It falls under the same umbrella as ibuprofen and naproxen—those are drugs millions grab without thinking during a nasty headache or a rough day with sore muscles. Fenbufen belongs to a family called nonsteroidal anti-inflammatory drugs, or NSAIDs. People reach for these pills to get a break from pain, but it helps to know what comes with the territory. Knowing what to expect can steer us clear of trouble and spot a problem before it turns serious.
Stomach problems come up often. Taking Fenbufen on an empty stomach can quickly turn into indigestion, nausea, or mild heartburn. Sometimes, it feels like a tight, uncomfortable knot after eating. Some folks have described a lingering taste in their mouths. I can recall my own experience with NSAIDs, where one bad meal and a strong tablet left me clutching my belly for hours. Diarrhea and constipation sometimes join the list. These symptoms rarely stick around, but they make each dose a gamble, especially if you already have a sensitive stomach.
A headache can pop up, or you might notice feeling more tired than usual. These effects mirror the illness you’re fighting, which often confuses users. Drowsiness, dizziness, and sometimes blurred vision creep in, too, making it risky to drive or handle machines. I once tried to shake off a sprained ankle with pain pills, only to feel foggy at work. It cost me in productivity and a near-miss on the stairs.
Serious issues like stomach ulcers, bleeding, or liver damage are less common, but they turn up more quietly than expected. If you see blood in your stool or start vomiting what looks like coffee grounds, it’s not the medicine working—it’s your body asking for help. Long-term use or pairing Fenbufen with other painkillers multiplies these risks. Regular blood tests often catch liver changes before symptoms show, which I’ve learned through watching older family members navigate prescription regimens.
Rashes, severe itching, swelling in the face or throat, or trouble breathing signal an allergic reaction. These reactions don’t give much warning. Emergency care should always follow if swelling or trouble breathing crops up. It’s more than just a rash—these symptoms turn medicine into a threat rather than a help.
NSAIDs like Fenbufen carry extra baggage for people with heart or kidney issues. Raised blood pressure, fluid retention, or unexpected weight gain can spiral into dangerous territory for anyone with a heart condition. One friend ignored swollen ankles until chest pain landed her in the hospital. The doctor linked it back to her over-the-counter pain regime. Kidneys take a hit over time as well. The body quietly loses its edge at cleaning out toxins, which creates a hidden mess that’s easy to overlook until routine blood work reveals trouble.
Doctors often suggest the lowest dose for the shortest time. They warn against mixing multiple NSAIDs or adding alcohol, which just fans the flames in your stomach. Taking pills with food, regular check-ups, and candid conversations with the pharmacist make a difference. Honest accounts of pain history and family health provide extra layers of protection—transparency helps healthcare providers recommend safer plans.
Fenbufen plays a part in controlling pain, but the side effects invite us all to pay close attention. More awareness means fewer surprises and safer paths to relief.
People often look for options when dealing with pain, whether it’s from arthritis, injuries, or post-surgery recovery. Fenbufen steps in as a non-steroidal anti-inflammatory drug (NSAID) that’s trusted by doctors to help manage discomfort and swelling. It isn’t as well-known as ibuprofen or naproxen, but it has carved out a spot in clinics worldwide. Years of research support its use, although it doesn’t come without a few strings attached.
Doctors usually prescribe fenbufen in tablet form. Swallow a tablet with a glass of water, and avoid breaking or crushing it unless your doctor says otherwise. Food in your stomach helps, so take it during or right after meals. This isn’t about making it taste better—it’s about protecting your gut lining. NSAIDs can irritate the stomach and sometimes cause ulcers, especially if someone already struggles with digestive issues.
One thing patients tend to forget is the importance of timing. Fenbufen works best when spaced out at even intervals, such as every eight or twelve hours, depending on the dose set by the doctor. Missing a tablet probably won’t ruin your week, but regular missed doses lessen its ability to control inflammation and pain.
Anytime you add another drug to the mix, look closely for side effects. Most people tolerate fenbufen reasonably well. Still, stomach cramps, mild nausea, or indigestion show up from time to time. Whenever I took NSAIDs for an old soccer injury, I’d rinse them down with a full meal—and never on an empty stomach. That advice stuck with me through years of café meals and late-night takeouts after physiotherapy appointments.
Some patients may feel dizzy or develop a headache, although these effects rarely last long. More worrisome effects, like black stools, blood in vomit, or trouble breathing, signal an urgent problem. People with asthma, kidney trouble, or a history of stomach ulcers need to bring those conditions up before starting any NSAID, including fenbufen. This isn’t about scaring anyone; it’s about taking practical steps for your own safety.
With prescription drugs, you never want to play guessing games—especially with medicines that impact blood pressure or your kidneys. Fenbufen doesn’t mix well with blood thinners, certain antidepressants, or diuretics. Your pharmacist should know what you’re already taking. These professionals have a knack for catching those combinations that slip through the cracks.
Recent clinical studies and updated guidance from groups like the FDA and EMA stress this point: Over 30% of complications in pain medication come from avoidable drug interactions. Sharing your full medication list—over-the-counter products included—helps head off most preventable problems.
Using fenbufen only as long as necessary matches today’s best practice. If your pain lingers after a few weeks, circle back to your doctor for a check-in rather than topping up your own supply. Sometimes a simple dose adjustment solves the problem; sometimes, another medication fits better. Speaking openly, as early as possible, has kept more than a few friends and relatives out of the emergency room.
The right information, paired with honest conversations, sets people up for a smoother road to recovery. Fenbufen can provide meaningful relief—just don’t skip those common-sense steps at the start.
Fenbufen belongs to a category called nonsteroidal anti-inflammatory drugs, or NSAIDs. People use this type of medicine to manage pain or reduce inflammation—much like aspirin and ibuprofen. Doctors sometimes suggest NSAIDs for joint pain, arthritis, or even after dental work. While relief sounds appealing, not every pill suits every person, especially pregnant women.
Growing a new life changes a person’s routines. Many parents-to-be rethink every bite and bottle that comes close. Some things, like caffeine and sushi, spark debate. Medicines raise even more questions, since safety concerns affect more than just taste or preference. I remember my partner checking labels so closely during pregnancy that over-the-counter painkillers became an anxious topic, especially after our doctor mentioned risks.
With fenbufen, the conversation matters. Research points out that NSAIDs can cross the placenta. That means whatever benefit a parent receives, the baby’s body also absorbs a part of it. For years, medical experts have raised red flags around taking these medicines at different points in pregnancy.
Scientific studies don’t just guess—they look at large groups of births, side effects, and compare patterns. Reports show that using NSAIDs during early pregnancy links with a higher risk of miscarriage. Later in pregnancy, especially after 20 weeks, these drugs could cause complications with the baby's kidneys or even bring on high blood pressure in the unborn child. The FDA, which runs drug safety in the U.S., recommends avoiding NSAIDs in the second and third trimesters unless there’s no alternative.
Fenbufen, like its peers, blocks certain chemicals in the body that help with aches and swelling. Those same chemicals, called prostaglandins, do other work as well—like keeping the baby’s blood vessels and kidneys healthy before birth. Shutting them off too much or at the wrong time can set up problems nobody wants.
Pharmacies carry all kinds of pain remedies, but not every bottle fits a growing family’s needs. Pregnant patients need more than quick internet searches or advice from well-meaning friends. Doctors, pharmacists, and trained midwives stay on top of data, and they know what recent findings mean for real people. Most guides today steer parents-to-be away from fenbufen during pregnancy unless a doctor specifically recommends it.
For most aches, a safer route like paracetamol or acetaminophen might be an option. These have fewer links to pregnancy complications when taken as directed. Still, any medicine—even over-the-counter types—deserves a conversation first.
Sometimes well-intentioned advice turns into confusion: “My neighbor took painkillers and her baby’s fine,” or “Natural remedies are always safe.” Experience tells me that stories matter, but reliable choices come from evidence. Medication safety—not just comfort or convenience—has consequences reaching far beyond a rough night or a sore joint.
Trusted information, ongoing science, and honest talks with care providers do more for families than rumors or shortcuts. Fenbufen plays a role in pain management, but better choices put wellbeing at the front. Even though reaching for a quick fix feels tempting, talking things through supports healthier days for both parent and baby.
Anyone dealing with pain, swelling, or arthritis knows the relief a painkiller can bring. Fenbufen sits in the lineup of nonsteroidal anti-inflammatory drugs (NSAIDs) that help knock down these symptoms. People reach for it when joints hurt or pain lingers after an injury. Fenbufen can be useful, yet it never comes alone—many folks take it alongside other pills for blood pressure, cholesterol, diabetes, or anxiety. This is where the problem starts to grow.
Mixing medications is common for adults as they get older. Research from the CDC shows that around 40% of older Americans use five or more prescriptions daily. The trouble is, NSAIDs like Fenbufen can clash with several common treatments. Blood thinners—think warfarin or aspirin—are one example. Put Fenbufen in the mix and the risk of bleeding climbs quickly. Gastrointestinal bleeding, ulcers, or even bleeding in the brain become more likely.
Add blood pressure medication to the pile. ACE inhibitors or diuretics sometimes work less effectively when Fenbufen is present. The kidneys often take a hit, because NSAIDs can mess with blood flow and make existing problems worse. Every year, thousands land in the hospital from these interactions, often not realizing what triggered the spiral.
Doctors look at studies showing that NSAIDs as a group—including Fenbufen—double or triple the risk of bleeding issues when mixed with certain drugs. Academic journals point out kidney injury rises sharply among older people taking NSAIDs with common blood pressure pills. My own experience with relatives, and checking on elderly neighbors, drives home the worry. I’ve seen too many end up in the ER after mixing more than one painkiller or forgetting to check with a doctor before starting an NSAID.
Some might believe over-the-counter drugs don’t pose a risk, but Fenbufen, like many NSAIDs, doesn’t care if it’s prescription or not. Stomach ulcers or heart issues can show up with even a few weeks of steady use. This risk isn’t just theoretical—health systems spend billions each year patching up the results of medication interactions. Public health agencies keep sounding alarms about this issue for good reason.
Clear communication with healthcare providers turns out to be the main shield. Bringing a list of all pills—supplements included—to each appointment makes sense. Pharmacists catch more medication interactions than most people realize, so chatting with them before starting Fenbufen or any new NSAID can prevent a world of trouble. Keeping packages and patient leaflets pays off, as those tiny printouts sometimes hide key warnings.
People often rely on the internet for advice, yet nothing replaces a good face-to-face conversation with a doctor or pharmacist. Sharing concerns openly, even if something seems minor or embarrassing, steers people away from risk. Reporting any side effects or weird reactions quickly can keep small issues from turning serious.
Even though pills like Fenbufen seem like a simple solution for pain, taking a step back and asking about their mix with other medicines will protect health far more than any single drug ever could. Progress comes through staying informed, asking questions, and not treating painkillers as harmless helpers.
| Names | |
| Preferred IUPAC name | 3-(4-biphenylcarbonyl)propanoic acid |
| Other names |
Acutran Bifene Fenid Inflamaid |
| Pronunciation | /ˈfɛn.bjuː.fɛn/ |
| Identifiers | |
| CAS Number | 36330-85-5 |
| Beilstein Reference | 1723322 |
| ChEBI | CHEBI:7512 |
| ChEMBL | CHEMBL1500 |
| ChemSpider | 5323 |
| DrugBank | DB02373 |
| ECHA InfoCard | 100.049.264 |
| EC Number | EC 262-073-9 |
| Gmelin Reference | 1190602 |
| KEGG | D07967 |
| MeSH | D000081197 |
| PubChem CID | 3338 |
| RTECS number | DJ6000000 |
| UNII | 5894801ZP6 |
| UN number | UN3077 |
| CompTox Dashboard (EPA) | DTXSID6016872 |
| Properties | |
| Chemical formula | C16H14O2 |
| Molar mass | 296.353 g/mol |
| Appearance | white crystalline powder |
| Odor | Odorless |
| Density | 1.21 g/cm³ |
| Solubility in water | Very slightly soluble in water |
| log P | 3.6 |
| Vapor pressure | 1.92E-7 mmHg |
| Acidity (pKa) | 4.45 |
| Basicity (pKb) | 13.86 |
| Magnetic susceptibility (χ) | -84.6e-6 cm³/mol |
| Refractive index (nD) | 1.627 |
| Viscosity | Viscosity not reported. |
| Dipole moment | 3.01 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 387.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -117.8 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -6527 kJ/mol |
| Pharmacology | |
| ATC code | M01AE05 |
| Hazards | |
| Main hazards | May cause gastrointestinal irritation, ulceration or bleeding, hypersensitivity reactions, renal impairment, and central nervous system effects. |
| GHS labelling | GHS07, Warning, H315, H319, H335 |
| Pictograms | ATC code: M01AE05 |
| Signal word | Warning |
| Hazard statements | H373: May cause damage to organs through prolonged or repeated exposure. |
| Precautionary statements | Keep out of the reach of children. If medical advice is needed, have product container or label at hand. |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | 115°C |
| Autoignition temperature | 430°C |
| Lethal dose or concentration | Mouse oral LD50: 400 mg/kg |
| LD50 (median dose) | LD50 800 mg/kg (oral, rat) |
| NIOSH | Not established |
| PEL (Permissible) | Not established |
| REL (Recommended) | 1 g daily |
| Related compounds | |
| Related compounds |
Pranoprofen Suprofen Ketoprofen |
